|
Volumn 112, Issue 1, 2003, Pages 1-2
|
Parc-ing p53 in the cytoplasm
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOPLASM PROTEIN;
CYTOSKELETON PROTEIN;
GLUCOCORTICOID RECEPTOR;
GLUCOCORTICOID RECEPTOR ANTAGONIST;
LIGASE;
PROTEIN MDM2;
PROTEIN P53;
PROTEIN PARC;
UBIQUITIN;
UNCLASSIFIED DRUG;
VIMENTIN;
APOPTOSIS;
BREAST CARCINOMA;
CANCER CHEMOTHERAPY;
CARBOXY TERMINAL SEQUENCE;
CELL ACTIVITY;
CELL CYCLE;
CELL FUNCTION;
CELL HYPOXIA;
CELL NUCLEUS;
CELL PROLIFERATION;
CELLULAR DISTRIBUTION;
CYTOPLASM;
CYTOSKELETON;
DNA DAMAGE;
DOWN REGULATION;
ENZYME ACTIVITY;
GENE FUNCTION;
GENE INACTIVATION;
GENE MUTATION;
HUMAN;
MAMMARY GLAND;
NEUROBLASTOMA;
NEUROBLASTOMA CELL;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN BINDING;
PROTEIN DOMAIN;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN INTERACTION;
PROTEIN LOCALIZATION;
PROTEIN MOTIF;
PROTEIN STABILITY;
PROTEIN TRANSPORT;
SENSITIZATION;
SHORT SURVEY;
STRESS;
TUMOR CELL LINE;
TUMOR GROWTH;
TUMOR SUPPRESSOR GENE;
WILD TYPE;
|
EID: 0037428083
PISSN: 00928674
EISSN: None
Source Type: Journal
DOI: 10.1016/S0092-8674(02)01281-3 Document Type: Review |
Times cited : (25)
|
References (10)
|